Telemedicine and Telehealth in Movement Disorders: Principles, Strategies, Applications, and New Directions. This item is unavailable.Telemedicine and Telehealth in Movement Disorders: Principles, Strategies, Applications, and New Directions

The COVID-19 pandemic forced the world to pause and reevaluate how we operate specifically in medicine, shifting to telemedicine and telehealth. Integrating telemedicine and telehealth into the healthcare system enables patient safety and has been proven beneficial to medical and surgical practices including patient primary care. Telehealth in Movement Disorder: Principles, Strategies, Applications, and New Directions provides guidance on how to deliver clinical assessment and treatment to movements disorders patients through telemedicine. This book is divided into three distinct sections. The first section reviews general principles including strategies, standards, policies, and ethical aspects. The second section explores how telemedicine can be integrated into diagnosis, treatment, and care of patients with movement disorders including the use of new AI technologies. The final section discusses the integration and application of telemedicine in developing countries, including challenges and future opportunities.

• Reviews how to create a compliance and evidence-based telehealth practice
• Discusses the advantages and disadvantages of telemedicine and telepsychiatry for movements disorders
• Outlines new technologies Inertial measurement unit (IMU), Smart Textile and wearable healthcare

Dr. Wael Mohamed Yousef Mohamed is Professor of Basic Medical Science at the International Islamic University Malaysia, with over 20 years of experience in translational brain research and longevity science. He earned his MD and MSc in Clinical Pharmacology from Meoufia Medical School, Egypt, and his PhD in Neuroscience from The Pennsylvania State University. His research focuses on aging-related neurodegeneration, particularly Alzheimer’s and Parkinson’s diseases, aiming to understand the biological mechanisms of aging and develop therapies to extend healthspan. Dr. Mohamed investigates how aging influences neurodegenerative processes and seeks targeted interventions to promote healthy longevity. He is a member of leading neuroscience societies, including the Society for Neuroscience. His prior editorial work with Elsevier includes titles on neurodegenerative and movement disorders, reflecting his expertise in aging, neurodegeneration, and longevity.

Mitra Afshari, MD, MPH, is an assistant professor of Neurology at Rush University Medical Center in Chicago, the newest member of the Faculty in the Section of Movement Disorders. She is originally from Chicago, where she completed her undergraduate, medical school, and residency training at Northwestern University. She completed her fellowship in Movement Disorders at the University of California, San Francisco (UCSF), where she received comprehensive training in neurostimulation and neuromodulation for various Movement Disorders. During medical school, she also obtained her Masters’ in Public Health and traveled to Mexico, India, and Uganda for both clinical and research-related trips.Clinically, Afshari is adept at making decisions as it pertains to deep brain stimulation candidacy and programming, as well as performing botulinum toxin injections for dystonia, including limb injections. In addition to seeing patients, her primary research interests lie in Parkinson’s Disease, as it pertains to epidemiology, biomarkers, and clinical trials; deep brain stimulation therapy and other interventional therapies for advanced Movement disorders; telemedicine, teleneurology, and telerehabilitation; and palliative/supportive care in advanced Parkinsonian disorders.

Dr. Christine D. Esper is a neurologist in Atlanta, Georgia and is affiliated with multiple hospitals in the area, including Grady Memorial Hospital and Emory University Hospital. She received her medical degree from University of Illinois College of Medicine at Chicago and has been in practice for more than 20 years.